Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency
Keywords:
immunodeficiency, conventional Pap smear, colposcopy, cervical cancer, sensitivity, specificityAbstract
Introduction: Cervical cancer is the second most common cancer among women worldwide. The sensitivity of conventional Pap smear in detecting cervical lesions before cervical cancer is 51%, which means the false negative value is 49%. The aim of this study was to compare two methods for screening for cervical cancer in patients with secondary immunodeficiency, i.e., the conventional Pap smear and colposcopy.
Methods: This cross-sectional study was conducted on 101 immunodeficient patients who were referred to the Gynecologic Clinic at Shahid Sadughi Hospital in Yazd from March 2011 to August 2012. All patients underwent the Pap test, a colposcopy, and a cervical biopsy, with the latter being considered as the gold-standard test.
Results: The most frequency of immunodeficiency was noted among patients with rheumatoid arthritis (53.3%), and this was followed by patients who were undergoing chemotherapy (30.7%), patients with lupus erythematosus (12.9%), and patients with AIDS (3%). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the Pap smear were18.2, 98.5, 85.5, 71.3, and 72.2%, respectively. The respective values for colposcopy were 66.7, 98.94, 80, 97.9, and 97%, respectively.
Conclusion: In this study the accuracy, sensitivity, specificity, and negative predictive values of colposcopy were higher than those for the Pap smear in detecting high-grade, cervical, pre-malignant lesions (cervical intraepithelial neoplasia: CIN ≥ 2). Therefore, an annual colposcopy is advised for secondary immunodeficient patients instead of a Pap smear.
References
de Freitas AC, Coimbra EC, Leitão MdCG. Molecular targets of HPV oncoproteins: Potential biomarkers
for cervical carcinogenesis. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2014;1845(2):91- 103, doi: 10.1016/j.bbcan.2013.12.004. PMid: 24388872.
Spensley S, Hunter RD, Livsey JE, Swindell R, Davidson SE. Clinical outcome for chemoradiotherapy in
carcinoma of the cervix. Clinical oncology. 2009;21(1):49-55, doi: 10.1016/j.clon.2008.10.014. PMid:
Bueno CT, Silva CMDd, Barcellos RB, Silva Jd, Santos CRd, Menezes JES, et al. Association between
cervical lesion grade and micronucleus frequency in the Papanicolaou test. Genetics and molecular biology.
;37(3):496-9, doi: 10.1590/S1415-47572014000400004. PMid: 25249771, PMCid: PMC4171763.
Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review
and meta-analysis. Syst Rev. 2013;2(35):1-14, doi: 10.1186/2046-4053-2-35.
Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlader N, Horner M, et al. SEER cancer statistics
review, 1975-2005. Bethesda, MD: National Cancer Institute. 2008:1975-2005,
Berek JS, Hacker NF. Practical Gynecologic Oncology: Lippincott Williams & Wilkins; 2000.
Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of
the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. The New
England journal of medicine. 1992;327(18):1272-8, doi: 10.1056/NEJM199210293271804. PMid: 1328880
Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human
papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. The New England journal of
medicine. 2007;357(16):1579-88, doi: 10.1056/NEJMoa071430. PMid: 17942871
Zarchi MK, Binesh F, Kazemi Z, Teimoori S, Soltani HR, Chiti Z. Value of Colposcopy in the Early
Diagnosis of Cervical Cancer in Patients with Abnormal Pap Smears at Shahid Sadoughi Hospital, Yazd.
Asian Pacific Journal of Cancer Prevention. 2011;12:3439-41.
Karimi Zarchi M, Akhavan A, Fallahzadeh H, Gholami H, Dehghani A, Teimoori S. Outcome of cervical
cancer in Iranian patients according to tumor histology, stage of disease and therapy. Asian Pacific journal
of cancer prevention : APJCP. 2010;11(5):1289-91. PMid: 21198279.
Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital
human papillomavirus infection in young women. Journal of the National Cancer Institute.
;83(14):997-1003, http://dx.doi.org/10.1093/jnci/83.14.997. PMid: 1649312
Bernard E, Pons-Salort M, Favre M, Heard I, Delarocque-Astagneau E, Guillemot D, et al. Comparing
human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank
genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC infectious
diseases. 2013;13(1):1-11, doi: 10.1186/1471-2334-13-373. PMid: 23941096, PMCid: PMC3751808.
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus
infection in young women. The New England journal of medicine. 1998;338(7):423-8. doi:
1056/NEJM199802123380703, PMid: 9459645
Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the
Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.
Annals of internal medicine. 2000;132(10):810-9, doi: 10.1056/NEJM199802123380703. PMid: 9459645.
Novak E, Berek JS. Berek & Novak's gynecology: Lippincott Williams & Wilkins; 2007.
Alloub MI, Barr BB, McLaren KM, Smith IW, Bunney MH, Smart GE. Human papillomavirus infection
and cervical intraepithelial neoplasia in women with renal allografts. BMJ (Clinical research ed).
;298(6667):153-6, doi: 10.1136/bmj.298.6667.153.
Cordiner J, Sharp F, Briggs J. Cervical intraepithelial neoplasia in immunosuppressed women after renal
transplantation. Scottish medical journal. 1980;25(4):275-7. PMid: 7010590
Branca M, Rossi E, Alderisio M, Migliore G, Morosini PL, Vecchione A, et al. Performance of cytology
and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative
women. Cytopathology. 2001;12(2):84-93, doi: 10.1046/j.1365-2303.2001.00299.x. PMid: 11284952
Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the
diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstetrics and gynecology. 1998;91(4):626- 31, doi: 10.1016/S0029-7844(98)00006-4.
Gaudette LA, Gao RN, Freitag S, Wideman M. Cancer incidence by ethnic group in the Northwest
Territories (NWT) 1969-1988. Health reports. 1993;5(1):23-32. PMid: 8334235
Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, et al. Human papillomavirus
infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human
immunodeficiency virus infection. Journal of medical virology. 2008;80(5):847-55, doi:
1002/jmv.21170. PMid: 18360898.
Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, et al. Prevalence, risk factors, and
accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human
immunodeficiency virus. Gynecologic oncology. 1998;68(3):233-9, doi: 10.1006/gyno.1998.4938. PMid:
McAdam M, Sakita J, Tarivonda L, Pang J, Frazer IH. Evaluation of a cervical cancer screening program
based on HPV testing and LLETZ excision in a low resource setting. PloS one. 2010;5(10):e13266, doi:
1371/journal.pone.0013266. PMid:20949059, PMCid: PMC2951361
Yoshida Y, Sato S, Okamura C, Nishino Y, Yajima A. Evaluating the accuracy of uterine cancer screening
with the regional cancer registration system. Acta cytologica. 2001;45(2):157-62, doi: 10.1159/000327270.
PMid: 11284299
Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North
American studies on HPV testing in primary cervical cancer screening. International journal of cancer
Journal international du cancer. 2006;119(5):1095-101, doi: 10.1002/ijc.21955.
Hamashima C, Aoki D, Miyagi E, Saito E, Nakayama T, Sagawa M, et al. The Japanese guideline for
cervical cancer screening. Japanese journal of clinical oncology. 2010:hyq036.
Anderson JR, Paramsothy P, Heilig C, Jamieson DJ, Shah K, Duerr A. Accuracy of Papanicolaou test
among HIV-infected women. Clinical infectious diseases : an official publication of the Infectious Diseases
Society of America. 2006;42(4):562-8, doi: 10.1086/499357. PMid: 16421802.
Stephens PC, Sloboda Z, Grey S, Stephens R, Hammond A, Hawthorne R, et al. Is the receptivity of
substance abuse prevention programming affected by students' perceptions of the instructor? Health
education & behavior : the official publication of the Society for Public Health Education. 2009;36(4):724- 45, doi: 10.1177/1090198107304388. PMid: 18809689
Anastos K, Denenberg R, Solomon L. Human immunodeficiency virus infection in women. Medical
Clinics of North America. 1997;81(2):533-53, doi: 10.1016/S0025-7125(05)70530-7.
Hankins CA, Lamont JA, Handley M. Cervicovaginal screening in women with HIV infection: a need for
increased vigilance? CMAJ: Canadian Medical Association Journal. 1994;150(5):681. PMid:8313287,
PMCid: PMC1486337
Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human
papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative
women. Journal of the National Cancer Institute. 1999;91(3):226-36, doi: 10.1093/jnci/91.3.226. PMid:
Leibenson L, Banani S, Borer A, Meirovitz M, Avni YS, Singer D, et al. The prevalence of human
papillomavirus and cervical cytology abnormalities in women infected with human immunodeficiency
virus in southern Israel. The Israel Medical Association journal : IMAJ. 2011;13(1):34-8. PMid:21446234
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
